Based on its reported function, NOS1AP and the associated nitric oxide (NO) Synthase 1 may act as CF modifiers, and possibly activate intracellular cAMP to impinge on CFTR channel function [70,80,81,82]. Here, NOS1AP is linked to cystic fibrosis.